Anzeige
Mehr »
Mittwoch, 08.10.2025 - Börsentäglich über 12.000 News
Defence-Aktie mit Ritterschlag: Regierungs-Einladung zur größten Militärmesse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
479 Leser
Artikel bewerten:
(1)

The Foundation for Dermatology Education to Host the 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference - Saturday, December 11 - Monday, December 13, 2021

Registration now open to the only global multidisciplinary conference featuring world-class speakers, cutting-edge research presentations, case study reviews and more specifically in the field of Atopic Dermatitis

CHICAGO, Oct. 19, 2021.

"This year's annual conference agenda is packed with symposia focused on emerging therapies, panel discussions led by industry leaders, industry sessions sponsored by global companies and the awarding of the new Totally 'RAD' Award," said Dr. Jonathan I. Silverberg, MD, Ph.D., MPH, RAD Conference Chair. "The Annual Live RAD Conference offers great opportunities to hear about emerging therapies and industry 'hot topics' from the best in the field."

New to this year's Conference, the Totally "RAD" Award recognizes a healthcare provider in the dermatology field who has provided invaluable impact to patient care or research of AD. The recipient of the Totally "RAD" Award will receive a prize, complimentary registration to the December 2021 and 2022 conferences, as well as recognition on RAD's website and social media. Nominations are due by November 19, 2021. Submit your nominee at http://revolutionizingad.com/award.

"I am excited to again be a part of the Annual Live RAD Conference and look forward to presenting on the current findings between COVID-19 and atopic dermatitis at Sunday's Hot Topic session," said Jacob P. Thyssen, MD, Ph.D., DmSci. "It is an honor to be part of an educational conference whose mission is to create a learning space where - through cutting-edge abstracts, case studies and oral presentations - we can all share in the latest advances and late-breaking research."

RAD 2021 conference faculty include Jonathan I. Silverberg, MD, Ph.D., MPH, Conference Chair; Sabra Abbott, MD, Ph.D.; Katrina Abuabara, MD; Andrew Alexis, MD, Ph.D., MPH; Andrew Blauvelt, MD; Genery Booster, Ph.D.; Korey Capozza, MPH; Zelma Chiesa-Fuxench, MD, MSCE; Raj Chovatiya, MD, PhD; Mark Davis, MD; Aaron Drucker, MD; Anna Fishbein, MD; Phil Greenland, MD; Jon Hanifin, MD; Candrice Heath, MD; Peck Ong, MD; Amy S. Paller, MD, MS; Stephen Sheldon, DO; Eric Simpson, MD, MCR; Anne-Marie Singh, MD; Jacob P. Thyssen, MD, Ph.D., DmSci; Maria Wei, MD, Ph.D.; Prof. Stephan Weidinger, MD; Gil Yosipovitch, MD; and Phyllis Zee, MD, Ph.D.

More than 500 attendees are expected to register. To view the complete conference agenda, list of symposia leaders, and to register, visit RevolutionizingAD.com.

Saturday, December 11: 6:00 p.m. (EST) - Poster Viewing Opens

Sunday, December 12: 7:00 a.m. - 7:30 p.m. (EST)

Monday, December 13: 7:00 a.m. - 7:00 p.m. (EST)

Follow the RAD Conference on the following social media sites:

Linked in - linkedin.com/company/revolutionizingad/

Twitter - twitter.com/revatopicderm

Facebook - https://www.facebook.com/revolutionizingad

Press Contact: Patrice Melluso, patrice@revolutionizingad.com

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Foundation for Dermatology Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

###

About the Foundation for Dermatology Education

The Foundation for Dermatology Education is devoted to educating dermatologists, allergists, primary care clinicians, nurse practitioners, physicians assistants, nurses, and other allied health professionals, and patients about atopic dermatitis.

Related Images






Image 1: RAD_2021_Logo


Revolutionizing Atopic Dermatitis 2021 Logo



This content was issued through the press release distribution service at Newswire.com.

Attachment

  • RAD_2021_Logo (https://ml.globenewswire.com/Resource/Download/54f7ba9a-7b5b-46ca-a748-caba310187a4)

© 2021 GlobeNewswire (Europe)
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.